Company
Cardinal Health, Inc.
Headquarters: Dublin, OH, United States
Founded: 1971
Employees: 44,000
CEO: Mr. Michael C. Kaufmann
Market Cap
$31.29 Billion
USD as of Jan. 1, 2025
Cardinal Health, Inc. Categories
United States Healthcare Medical DistributionUnited States Healthcare United States Medical Distribution
Top Competitors by Market Capitalization
Industry: Medical Distribution
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $75.80 B |
| Cencora, Inc. | $47.92 B |
| Henry Schein, Inc. | $9.32 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $9.01 B |
| Sinopharm Group Co. Ltd | $8.15 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. It has a collaboration agreement with Journey Biosciences, Inc. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | $224.45 B |
| EBITDA | $2.91 B |
| Gross Profit TTM | $7.57 B |
| Profit Margin | 0.57% |
| Operating Margin | 1.05% |
| Quarterly Revenue Growth | -4.30% |
Stocks & Indices
Cardinal Health, Inc. has the following listings and related stock indices.
Stock: NYSE: CAH wb_incandescent
Stock: BCBA: CAH wb_incandescent
Stock: Bovespa: C1AH34 wb_incandescent
Stock: FSX: CLH wb_incandescent
Product & Services
Medical and pharmaceutical products and services
Key People
Founder(s): Robert D. Walter
Michael Kaufmann (CEO)